NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).

Swain, SM; Tang, G; Brauer, HA; Goerlitz, D; Lucas, PC; Harris, BT; Robidoux, A; Geyer, CE; Rastogi, P; Mamounas, EP; Wolmark, N

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):